In our recent Metastatic May campaign, the theme was ‘The Cost of Living’. Living with metastatic breast cancer affects personal finances, careers, and overall income. But we also explored the
I contacted METUPUK when I was diagnosed as a primary patient in 2018…
I contacted METUPUK when I was diagnosed as a primary patient in 2018. Even though my mum died of Metastatic Breast Cancer (MBC) in 2015, I had no real understanding
NICE Methodology Roundtable Discussion
In November 2023 METUPUK trustee Madeleine Meynell was a panel member at the event Optimising NICE outcomes: Policy roundtable on the evolution of NICE methodology and how patient organisations can
Herceptin report re access to 3rd and subsequent line of therapy problem with drug access
10th July 2020 Hi Debbie, Trying to condense the points from the June email with attachments I sent you. Going forward what we would like now is – for you